Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 24% ± 5% | |
| endothelial cell | 4 studies | 26% ± 2% | |
| basal cell | 4 studies | 23% ± 12% | |
| glutamatergic neuron | 4 studies | 26% ± 9% | |
| astrocyte | 3 studies | 20% ± 1% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 20% ± 0% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3188.45 | 1445 / 1445 | 100% | 31.10 | 183 / 183 |
| lung | 99% | 2154.81 | 575 / 578 | 100% | 22.05 | 1155 / 1155 |
| breast | 100% | 2989.93 | 459 / 459 | 99% | 25.59 | 1109 / 1118 |
| kidney | 100% | 1389.29 | 89 / 89 | 99% | 28.10 | 891 / 901 |
| uterus | 100% | 2030.18 | 170 / 170 | 99% | 22.91 | 453 / 459 |
| thymus | 100% | 1762.63 | 651 / 653 | 99% | 16.46 | 598 / 605 |
| prostate | 100% | 2296.44 | 244 / 245 | 99% | 17.89 | 495 / 502 |
| intestine | 100% | 2751.68 | 966 / 966 | 97% | 18.76 | 512 / 527 |
| bladder | 100% | 2415.76 | 21 / 21 | 97% | 16.71 | 487 / 504 |
| stomach | 99% | 1675.84 | 357 / 359 | 97% | 19.54 | 277 / 286 |
| ovary | 100% | 2282.33 | 180 / 180 | 96% | 11.25 | 413 / 430 |
| skin | 100% | 3892.11 | 1808 / 1809 | 94% | 21.57 | 442 / 472 |
| adrenal gland | 98% | 1045.28 | 252 / 258 | 92% | 12.13 | 212 / 230 |
| pancreas | 91% | 878.36 | 299 / 328 | 98% | 22.28 | 175 / 178 |
| brain | 73% | 656.34 | 1932 / 2642 | 94% | 8.88 | 665 / 705 |
| liver | 59% | 430.62 | 134 / 226 | 68% | 7.27 | 277 / 406 |
| blood vessel | 100% | 4761.17 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 1340.66 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 30.60 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.02 | 1 / 1 |
| adipose | 100% | 2867.99 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 2091.54 | 802 / 803 | 0% | 0 | 0 / 0 |
| heart | 97% | 2678.03 | 839 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 13.43 | 27 / 29 |
| eye | 0% | 0 | 0 / 0 | 70% | 7.93 | 56 / 80 |
| peripheral blood | 58% | 798.15 | 539 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051260 | Biological process | protein homooligomerization |
| GO_0016567 | Biological process | protein ubiquitination |
| GO_0035556 | Biological process | intracellular signal transduction |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0097602 | Molecular function | cullin family protein binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | KCTD9 |
| Protein name | BTB/POZ domain-containing protein KCTD9 Potassium channel tetramerization domain containing 9 |
| Synonyms | |
| Description | FUNCTION: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex, which mediates the ubiquitination of target proteins, leading to their degradation by the proteasome. . |
| Accessions | A0AA34QVI4 Q7L273 ENST00000519665.5 ENST00000221200.9 K7ENB5 ENST00000523140.5 K7EQN1 ENST00000710397.1 |
